Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic

Eimear C Morrissey1, Hannah Durand2, Robby Nieuwlaat3

  • 1School of Psychology, National University of Ireland, Galway, Ireland. e.morrissey6@nuigalway.ie.

Systematic Reviews
|June 9, 2016
PubMed

Insights

Improving medication adherence in hypertension is crucial for cardiovascular health. This review evaluates interventions, identifying barriers and facilitators to enhance treatment effectiveness and patient outcomes.

Area of Science:

  • Pharmacology and Cardiovascular Health
  • Public Health and Patient Adherence

Background:

  • Pharmacological treatment of hypertension significantly reduces cardiovascular morbidity and mortality.
  • However, medication adherence rates among treated hypertensive patients range from 20% to 50%, compromising treatment efficacy.
  • This highlights the need for effective interventions to improve adherence.

Purpose of the Study:

  • To systematically review and evaluate the effectiveness of medication adherence interventions specifically for hypertension.
  • To explore barriers and facilitators targeted by these interventions.
  • To investigate the relationship between targeted theoretical domains and the effect size on blood pressure control.

Main Methods:

  • This study is an update to the Cochrane Review by Nieuwlaat et al. (2014).
  • A systematic literature search will be conducted, with independent screening and data extraction by two authors.
  • Methodological quality will be assessed using the Cochrane Collaboration Risk of Bias Tool, followed by meta-analysis and identification of theoretical factors using the Theoretical Domains Framework.

Main Results:

  • This section is to be populated upon completion of the review and meta-analysis.

Conclusions:

  • This review will provide quantitative data on the effectiveness of hypertension medication adherence interventions.
  • It aims to identify which theoretical domains are most associated with successful interventions.
  • The findings will also highlight domains that have been underutilized in intervention development for hypertension management.
Abstract

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
613
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
382
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
821
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K